Thais M. Sielecki

1.5k total citations
26 papers, 1.1k citations indexed

About

Thais M. Sielecki is a scholar working on Organic Chemistry, Surgery and Molecular Biology. According to data from OpenAlex, Thais M. Sielecki has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Thais M. Sielecki's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Macrophage Migration Inhibitory Factor (5 papers) and Nuclear Receptors and Signaling (4 papers). Thais M. Sielecki is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Macrophage Migration Inhibitory Factor (5 papers) and Nuclear Receptors and Signaling (4 papers). Thais M. Sielecki collaborates with scholars based in United States, Germany and Poland. Thais M. Sielecki's co-authors include Pamela A. Benfield, George L. Trainor, John F. Boylan, A. I. MEYERS, John A. Taylor, Shaker A. Mousa, Ruth R. Wexler, John Wityak, Scott J. Weir and James R. Pruitt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Gastroenterology.

In The Last Decade

Thais M. Sielecki

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thais M. Sielecki United States 18 420 378 280 203 104 26 1.1k
Sonia Lamontagne Canada 19 314 0.7× 525 1.4× 191 0.7× 87 0.4× 95 0.9× 22 1.3k
Laurie Churchill United States 13 260 0.6× 686 1.8× 263 0.9× 156 0.8× 146 1.4× 20 1.3k
John Wityak United States 24 581 1.4× 554 1.5× 179 0.6× 89 0.4× 143 1.4× 46 1.4k
Andrew S. Tasker United States 20 482 1.1× 681 1.8× 230 0.8× 132 0.7× 35 0.3× 45 1.4k
Vered Klinghofer United States 21 372 0.9× 580 1.5× 338 1.2× 99 0.5× 60 0.6× 27 1.3k
Bertrand Leblond France 17 259 0.6× 665 1.8× 142 0.5× 101 0.5× 61 0.6× 29 1.2k
Kiyohiro Nishikawa Japan 21 348 0.8× 767 2.0× 397 1.4× 88 0.4× 81 0.8× 56 1.4k
Roland Feifel Switzerland 21 338 0.8× 769 2.0× 164 0.6× 155 0.8× 206 2.0× 36 1.3k
Christopher J. O’Donnell United States 27 799 1.9× 835 2.2× 483 1.7× 73 0.4× 52 0.5× 54 2.1k
William D. Holmes United States 14 225 0.5× 994 2.6× 432 1.5× 339 1.7× 60 0.6× 21 1.5k

Countries citing papers authored by Thais M. Sielecki

Since Specialization
Citations

This map shows the geographic impact of Thais M. Sielecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thais M. Sielecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thais M. Sielecki more than expected).

Fields of papers citing papers by Thais M. Sielecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thais M. Sielecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thais M. Sielecki. The network helps show where Thais M. Sielecki may publish in the future.

Co-authorship network of co-authors of Thais M. Sielecki

This figure shows the co-authorship network connecting the top 25 collaborators of Thais M. Sielecki. A scholar is included among the top collaborators of Thais M. Sielecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thais M. Sielecki. Thais M. Sielecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chatterjee, Shampa, Ralph A. Pietrofesa, Kyewon Park, et al.. (2019). LGM2605 Reduces Space Radiation-Induced NLRP3 Inflammasome Activation and Damage in In Vitro Lung Vascular Networks. International Journal of Molecular Sciences. 20(1). 176–176. 19 indexed citations
2.
Woolbright, Benjamin L., et al.. (2019). MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential. Nature Reviews Urology. 16(5). 318–328. 79 indexed citations
3.
Flayer, Cameron H., Erik D. Larson, Christopher M. Royer, et al.. (2019). Ozone-induced enhancement of airway hyperreactivity in rhesus macaques: Effects of antioxidant treatment. Journal of Allergy and Clinical Immunology. 145(1). 312–323. 17 indexed citations
4.
Nagarajan, Priyadharsini, Kathleen L. Tober, Donna F. Kusewitt, et al.. (2014). MIF Antagonist (CPSI-1306) Protects against UVB-Induced Squamous Cell Carcinoma. Molecular Cancer Research. 12(9). 1292–1302. 18 indexed citations
5.
Choudhary, Shilpa, Poornima Hegde, James R. Pruitt, et al.. (2013). Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis. Carcinogenesis. 34(12). 2891–2899. 46 indexed citations
6.
Dzierba, Carolyn D., Thais M. Sielecki, Argyrios G. Arvanitis, et al.. (2012). Synthesis and structure–activity relationships of pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(15). 4986–4989. 5 indexed citations
7.
Wehner, Sven, Tim O. Vilz, Thais M. Sielecki, et al.. (2012). The novel orally active guanylhydrazone CPSI-2364 prevents postoperative ileus in mice independently of anti-inflammatory vagus nerve signaling. Langenbeck s Archives of Surgery. 397(7). 1139–1147. 11 indexed citations
8.
Kithcart, Aaron, Gina Mavrikis Cox, Thais M. Sielecki, et al.. (2010). A small‐molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease. The FASEB Journal. 24(11). 4459–4466. 38 indexed citations
9.
Terrazas, Luis I., Caroline C. Whitacre, Aaron Kithcart, et al.. (2010). Macrophage migration inhibitory factor is a therapeutic target in treatment of non‐insulin‐dependent diabetes mellitus. The FASEB Journal. 24(7). 2583–2590. 51 indexed citations
10.
Wehner, Sven, Tim O. Vilz, Dimitrios Pantelis, et al.. (2008). Inhibition of p38 Mitogen-Activated Protein Kinase Pathway as Prophylaxis of Postoperative Ileus in Mice. Gastroenterology. 136(2). 619–629. 59 indexed citations
11.
Lai, Zhihong, Tao Yang, Young B. Kim, et al.. (2002). Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors. Proceedings of the National Academy of Sciences. 99(23). 14734–14739. 86 indexed citations
12.
Carini, David J., Robert F. Kaltenbach, Jie Liu, et al.. (2001). Identification of selective inhibitors of cyclin dependent kinase 4. Bioorganic & Medicinal Chemistry Letters. 11(16). 2209–2211. 37 indexed citations
13.
Sielecki, Thais M., Jie Liu, J.K. Muckelbauer, et al.. (2001). Quinazolines as cyclin dependent kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(9). 1157–1160. 73 indexed citations
14.
Sielecki, Thais M., Jie Liu, Shaker A. Mousa, et al.. (2001). Synthesis and pharmacology of modified amidine isoxazoline glycoprotein IIb/IIIa receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 11(16). 2201–2204. 56 indexed citations
15.
Sielecki, Thais M., John Wityak, Shaker A. Mousa, et al.. (2000). Ring constrained analogues of β-alanine-containing GPIIb/IIIa receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(5). 449–452. 6 indexed citations
16.
Liang, Long, Richard L. Harlow, C.M. Foris, et al.. (2000). Crystalline versus Amorphous Content of Lumaxis™ Analog XP280 Using X‐ray and Electron Diffraction Methods. Journal of Pharmaceutical Sciences. 89(10). 1237–1242. 1 indexed citations
17.
Mousa, Shaker A., et al.. (1998). XV454, a Novel Nonpeptide Small-Molecule Platelet GIIb/IIIa Antagonist with Comparable Platelet αIIbβ3-Binding Kinetics to c7E3. Journal of Cardiovascular Pharmacology. 32(5). 736–744. 13 indexed citations
18.
Mousa, Shaker A., Richard E. Olson, Jeffrey M. Bozarth, et al.. (1998). Oral Antiplatelet Efficacy and Specificity of a Novel Nonpeptide Platelet GPIIb/IIIa Receptor Antagonist, DMP 802. Journal of Cardiovascular Pharmacology. 32(2). 169–176. 13 indexed citations
19.
Wityak, John, Thais M. Sielecki, Donald Pinto, et al.. (1997). The Discovery of Potent Isoxazoline Glycoprotein IIb/IIIa Receptor Antagonists. Journal of Medicinal Chemistry. 40(8). 1292–1292. 4 indexed citations
20.
Mousa, Shaker A., Mark S. Forsythe, William Lorelli, et al.. (1996). Novel nonpeptide antiplatelet glycoprotein llb/llla receptor antagonist, DMP754. Coronary Artery Disease. 7(10). 767–774. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia Lamontagne Breakdown of academic impact, for papers by Laurie Churchill Breakdown of academic impact, for papers by John Wityak Breakdown of academic impact, for papers by Andrew S. Tasker Breakdown of academic impact, for papers by Vered Klinghofer Breakdown of academic impact, for papers by Bertrand Leblond Breakdown of academic impact, for papers by Kiyohiro Nishikawa Breakdown of academic impact, for papers by Roland Feifel Breakdown of academic impact, for papers by Christopher J. O’Donnell Breakdown of academic impact, for papers by William D. Holmes
Rankless by CCL
2026